Home / Stocks / HALO

HALO insider trading

HALOZYME THERAPEUTICS, INC. — open-market insider buys and $1M+ sells from SEC Forms 3, 4 and 5.
Insider buys · 24 mo
0
Bought · 24 mo
$0
Buys · last 90 days
0 · $0
Most recent buy

Recent insider filings

FiledInsiderTypeSharesPriceValue
2026-08-19Torley Helen
PRESIDENT AND CEO
Sold9,600$107.22$1.0M
2026-06-03Torley Helen
PRESIDENT AND CEO
Sold16,600$66.31$1.1M
2026-04-02Torley Helen
PRESIDENT AND CEO
Sold34,800$64.77$2.3M
2026-03-10Caudill Cortney
SVP, CHIEF OPERATING OFFICER
Sold17,900$67.75$1.2M
2026-03-04Torley Helen
PRESIDENT AND CEO
Sold15,322$69.80$1.1M
2025-11-12Torley Helen
PRESIDENT AND CEO
Sold19,900$68.71$1.4M
2025-09-11LaBrosse Nicole
SVP, CHIEF FINANCIAL OFFICER
Sold13,240$75.93$1.0M
2025-09-04Torley Helen
PRESIDENT AND CEO
Sold16,288$73.70$1.2M
2025-08-13Torley Helen
PRESIDENT AND CEO
Sold18,717$63.01$1.2M
2025-07-10Torley Helen
PRESIDENT AND CEO
Sold19,792$56.43$1.1M
2025-06-24Torley Helen
PRESIDENT AND CEO
Sold40,000$52.77$2.1M

See HALO on the chart

Every insider buy and sell for HALO plotted on the price, the full two-year history, cluster scores and daily updates — in the members area, $29/month. A free quarterly sample of the whole dataset needs no account.

Open the browserFree sample
Data from the SEC EDGAR ownership filings, refreshed daily. Only open-market purchases (transaction code P) and sales of $1M or more are shown; grants, option exercises and tax withholding are excluded because they run on schedules set years earlier. Not investment advice.